Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy of flexibly dosed paliperidone
extended-release (mechanism to dissolve a drug over time in order to be released slower and
steadier into the blood stream) in improving or maintaining the subjective symptoms of the
participants in three participants' groups (that is, by the reason to switch: lack of
efficacy group, lack of tolerability group, and lack of compliance group) who switched from
other previous antipsychotic drugs to paliperidone extended-release tablets at flexible
doses.